NeuroMetrix, Inc. Announces Date for 2011 First Quarter Financial Results Conference Call WALTHAM, Mass., Apr 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011.
NeuroMetrix to Preview New Product Targeted at Diabetes Market at the American Association of Clinical Endocrinologists Annual Meeting WALTHAM, Mass., Apr 13, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat ® | DPNCheck
NeuroMetrix Announces Diabetic Neuropathy Scientific Advisory Board WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development
NeuroMetrix to Present at Canaccord Genuity Musculoskeletal Conference WALTHAM, Mass., Feb 09, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai N.
NeuroMetrix, Inc. Announces Date for 2010 Fourth Quarter Financial Results Conference Call WALTHAM, Mass., Jan 26, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2010 fourth quarter financial results before the opening of the market on February 3, 2011.
